Updates

Ref: MHL/Sec&Legal/2026-27/20 July 05, 2026 BSE Limited National Stock Exchange of India Ltd. Scrip Code: 542650 Scrip Symbol: METROPOLIS Dear Sir/Madam, Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Code of Fair Disclosure of Unpublished Price Sensitive Information & Policy for Legitimate Purpose in terms of Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has provided a business update for the quarter ended June 30, 2026. This update seeks to provide an overall summary of the operating performance and demand trends witnessed during the quarter ending June 30, 2026. A detailed update will follow once the Board of Directors approves the financial results for Q1FY27. Consolidated Key Business Highlights of Q1FY27: 1. Revenue grew by approximately 16% on a Y-o-Y basis with patient volumes being the major driver along with realization benefits due to product mix change. 2. The TruHealth Wellness and Specialty segments are the fastest growing segments for the quarter. 3. B2C registered healthy volume growth, driven by increased throughput from the expanded center network. B2B volumes also grew, supported by higher wallet share and new customer acquisition, backed by improved service quality and delivery levels. 4. EBITDA margins improved on a year-on-year basis in line with guidance. On quarter-on-quarter basis, margins remained largely stable. The quarterly business update is on a consolidated basis. The financial results of Q1FY27 are subject to review by Auditors. Thanking you, Yours faithfully, For Metropolis Healthcare Limited Kamlesh C Kulkarni Head – Legal & Secretarial